AVDL
AVDL
NASDAQ · Pharmaceuticals

Avadel Pharmaceuticals

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$21.64
+0.01 (+0.05%)
As of Mar 22, 10:03 PM ET ·
Analyst Consensus
Hold
16
Analysts
High
Coverage
Buy 6 38%
Hold 10 63%
Sell 0 0%
Price Target
Analyst Price Target +437.3% upside
Low Target $84.09
Average Target $116.27
High Target $133.85
Current Price $21.64
Current
$21.64
Target
$116.27
$84.09 $116.27 avg $133.85
Scenario Analysis
Bear Case
$84.09
288.6%
Low target
Base Case
$116.27
+437.3%
Avg target
Bull Case
$133.85
+518.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$23.57
-8.2% from high
52-Week Low
$6.38
+239.2% from low
50-Day SMA
$21.51
+0.6% vs SMA
200-Day SMA
$15.56
+39.1% vs SMA
RSI (14)
61.3
Neutral
Target vs 52W High
$116.27
+393.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%